Delivery Order HHSN272201300022I-HHSN27200003
Award Date 8/5/14
Potential Completion Date 7/31/23
Potential Value $2.1M
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Baltimore, MD 21201, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
2
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) as the prime contractor. The $2,752,906.46 contract is for Vaccine Treatment and Evaluation Units (VTEU), a major NIAID program that supports clinical trials and medical research on vaccines and treatments for infectious diseases. The contract is a delivery order under the larger VTEU...
- This is a federal contract award to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) program, administered by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract has a ceiling value of $2,549,094.56 and was awarded on July 2, 2015, with a performance period ending on December 31, 2022. The contract was issued as a delivery order under the VTEU indefinite...
- This is a delivery order issued under the Vaccine and Treatment Evaluation Units (VTEU) contract, which is a multiple award indefinite delivery/indefinite quantity (IDIQ) contract managed by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) under the Department of Health and Human Services (HHS). The $59,220 award was made to the University of Maryland, Baltimore (UMB) to provide vaccine treatment evaluation services as part of the...
- This is a federal contract award made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the University of Maryland, Baltimore (UMB) for the Vaccine and Treatment Evaluation Units (VTEU) program. The award, made on September 20, 2016, has a ceiling value of $3,600,570.60 and an ultimate completion date of August 31, 2021. This is a delivery order contract with a cost-no-fee pricing type. The contract is not...
- This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) contract vehicle. The $488,933.02 award is for a cost-reimbursement contract with no fee to support VTEU activities. UMB, a major public research university, is serving as the prime contractor on this task order, which does not have a...
- This is a task order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Vehicle (IDV). The $344,492 task order supports biomedical research activities under the VTEU program. The VTEU program is a major NIH initiative to conduct clinical trials and evaluations of vaccines and treatments for...
- This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery/Indefinite Quantity (IDIQ) contract. The $8,784,601.46 award is for consultation and testing of cytokine levels and cell activation in clinical samples, which supports the VACCINE TREATMENT EVALUATION...
- This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH), a civilian agency. The contract was awarded to the University of Maryland, Baltimore (UMB) on April 10, 2015 and has a ceiling value of $882,112.66. It is a task order under the Vaccine and Treatment Evaluation Units (VTEU) Indefinite Delivery Vehicle (IDV), which allows NIAID to place orders for medical research and services...
- This is a delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to the University of Maryland, Baltimore (UMB) under the Vaccine and Treatment Evaluation Units (VTEU) indefinite delivery, indefinite quantity (IDIQ) contract. The order is for VTEU protocol development, implementation, and assays under Task Areas B-D, with a period of performance through September 30, 2023 and a ceiling value of...
- This federal contract award to the University of Maryland, Baltimore (UMB) was made by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), for Vaccine Treatment and Evaluation Units (VTEU). The $910,006.01 contract is a delivery order under the VTEU indefinite delivery vehicle (IDV), which allows NIAID to order various medical research and clinical trial services from UMB as needed. The contract has no set-aside designation. As...